| |
| |
|
| Insider
Information: |
Chavez Christopher G |
| Relationship: |
Director |
| City: |
Plano |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
396,507 |
|
|
Indirect Shares
|
273,626 |
|
|
| Direct
Value |
$7,558 |
|
|
|
Indirect Value
|
$1,306 |
|
|
| Total
Shares |
670,133 |
|
|
| Total
Value |
$8,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -85.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
St Jude Medical Inc |
STJ |
President, ANS Division |
2009-05-01 |
16,224 |
2009-05-01 |
0 |
Premium* |
|
|
Trivascular Technologies, Inc. |
TRIV |
|
2016-02-03 |
0 |
2014-04-15 |
207,986 |
Premium* |
|
|
Endologix Inc |
ELGX |
Director |
2018-05-29 |
378,346 |
2016-02-29 |
65,640 |
Premium* |
|
|
Nuvectra Corp |
NVTR |
Director |
2019-09-21 |
1,937 |
2019-06-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVTR |
Nuvectra Corp |
Director |
• • – |
2019-09-21 |
4 |
OE |
$1.53 |
$1,481 |
D/D |
968 |
1,937 |
0 |
- |
|
| NVTR |
Nuvectra Corp |
Director |
• • – |
2019-06-21 |
4 |
OE |
$3.60 |
$3,488 |
D/D |
969 |
969 |
0 |
- |
|
| ELGX |
Endologix Inc |
Director |
– • – |
2018-05-29 |
4 |
S |
$5.64 |
$91 |
D/D |
(16) |
378,346 |
0 |
- |
|
| ELGX |
Endologix Inc |
Director |
– • – |
2017-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22,822 |
378,362 |
0 |
- |
|
| ELGX |
Endologix Inc |
Director |
– • – |
2016-04-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
328,586 |
355,540 |
0 |
- |
|
| ELGX |
Endologix Inc |
Director |
– • – |
2016-02-29 |
4 |
A |
$0.00 |
$0 |
I/I |
131,280 |
65,640 |
0 |
- |
|
| ELGX |
Endologix Inc |
Director |
– • – |
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
285,280 |
312,234 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
President, CEO and Chairman |
• • – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(728,561) |
0 |
0 |
- |
|
| ELGX |
Endologix Inc |
Director |
– • – |
2016-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,954 |
26,954 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
President, CEO and Chairman |
• • – |
2016-02-03 |
4 |
D |
$5.62 |
$251,293 |
D/D |
(44,714) |
668,393 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
President, CEO and Chairman |
• • – |
2016-02-03 |
4 |
OE |
$0.00 |
$96,590 |
D/D |
113,323 |
689,672 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
President, CEO and ChairmanOff |
• • – |
2014-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
446,060 |
|
- |
|
| TRIV |
Trivascular Technologies,... |
President, CEO and ChairmanOff |
• • – |
2014-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
207,986 |
|
- |
|
| STJ |
St Jude Medical Inc |
President, ANS Division |
• – – |
2009-05-01 |
4 |
B |
$33.17 |
$497,550 |
D/D |
15,000 |
16,224 |
2.74 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
